Abeona Therapeutics Inc. (ABEO)

Abeona Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	34.43	14.47	14.22	32.94	12.6	129.26
Short-Term Investments	88.28	37.75	37.93	12.09	82.44	-
Cash & Short-Term Investments	122.71	52.23	52.15	45.02	95.03	129.26
Cash Growth	233.70%	0.15%	15.82%	-52.62%	-26.48%	52.13%
Accounts Receivable	-	-	-	3	-	-
Other Receivables	1.64	2.44	0.19	-	-	-
Receivables	1.64	2.44	0.19	3	-	-
Prepaid Expenses	1.22	0.73	0.42	2.38	2.71	3.13
Restricted Cash	0.34	0.34	0.34	5.89	-	-
Total Current Assets	125.9	55.74	53.1	56.29	97.74	132.39
Property, Plant & Equipment	8	7.99	11.07	21.74	18.35	21.2
Goodwill	-	-	-	-	32.47	32.47
Other Intangible Assets	-	-	-	1.38	1.5	36.18
Other Long-Term Assets	0.1	0.28	0.04	0.17	1.14	1.14
Total Assets	134	64	64.21	79.59	151.2	223.38
Accounts Payable	3.1	1.86	1.81	4.33	4.7	3.76
Accrued Expenses	4.92	5.99	3.99	5.59	3.41	5.54
Current Portion of Long-Term Debt	2.22	-	-	-	0.33	-
Current Portion of Leases	1.79	1	1.77	1.82	1.71	1.7
Current Unearned Revenue	-	-	-	-	0.3	0.3
Other Current Liabilities	4.81	4.58	0.2	4.9	31.52	27.4
Total Current Liabilities	16.84	13.42	7.78	16.62	41.96	38.7
Long-Term Debt	16.13	-	-	-	1.43	-
Long-Term Leases	3.02	4.4	5.85	7.56	5.26	6.25
Other Long-Term Liabilities	24.77	31.35	23.82	13.04	-	-
Total Liabilities	60.76	49.18	37.45	37.22	48.65	44.95
Common Stock	0.42	0.27	0.18	1.47	0.96	0.84
Additional Paid-In Capital	846.65	764.15	722.05	696.56	672.3	664.06
Retained Earnings	-773.7	-749.52	-695.34	-655.64	-570.7	-486.47
Comprensive Income & Other	-0.13	-0.07	-0.13	-0.03	-0.01	-
Total Common Equity	73.24	14.83	26.76	42.37	102.55	178.43
Shareholders' Equity	73.24	14.83	26.76	42.37	102.55	178.43
Total Liabilities & Equity	134	64	64.21	79.59	151.2	223.38
Total Debt	23.17	5.4	7.63	9.38	8.73	7.95
Net Cash (Debt)	99.54	46.83	44.52	35.65	86.3	121.31
Net Cash Growth	223.21%	5.17%	24.90%	-58.70%	-28.86%	42.77%
Net Cash Per Share	3.38	2.19	5.66	9.05	23.28	60.23
Filing Date Shares Outstanding	43.31	27.36	17.71	5.9	3.95	3.34
Total Common Shares Outstanding	41.66	26.52	17.72	5.89	3.85	3.34
Working Capital	109.06	42.32	45.32	39.67	55.78	93.69
Book Value Per Share	1.76	0.56	1.51	7.20	26.67	53.34
Tangible Book Value	73.24	14.83	26.76	40.98	68.59	109.79
Tangible Book Value Per Share	1.76	0.56	1.51	6.96	17.84	32.82
Machinery	9.2	7.92	9.02	10.98	9.98	8.74
Construction In Progress	-	-	-	3.22	0.07	-
Leasehold Improvements	8.74	8.6	8.61	8.6	8.6	8.57

Source: S&P Capital IQ. Standard template. Financial Sources.